Active substanceOrnithineOrnithine
Similar drugsTo uncover
  • Hepa-Mertz
    granules inwards 
  • Hepa-Mertz
    concentrate d / infusion 
  • Larnamine
    concentrate d / infusion 
    FARMAK, JSC     Ukraine
  • OrnilaTex®
    concentrate d / infusion 
  • Ornithine
    granules inwards 
  • Ornithine canon
    granules inwards 
  • Dosage form: & nbspGranules for solution for oral administration
    Composition:

    5 g of granules contain

    Active substance: L-ornithine-L-aspartate 3 g.

    Excipients: acid citric anhydrous 0.55 g flavor lemon 0,12 g flavoring orange 0.2 g sodium saccharinate (saccharin sodium) 0.0045 g sodium cyclomate 0.0405 g dye sunset yellow 0.0005 g polyvinylpyrrolidone (povidone) 0.05 g of fructose (levulose) 1.1345 g

    Description:

    A mixture of orange and white granules.

    Pharmacotherapeutic group:Preparations for the treatment of liver diseases
    ATX: & nbsp

    A.05.B.A.06   Ornithine oxoglurate

    Pharmacodynamics:

    Has a detoxification effect, reducing the elevated level of ammonia in the body, in particular, with liver diseases. The effect of the drug is associated with its participation in the ornithine cycle of urea formation Krebs (activates the cycle, restoring the activity of liver enzymes: ornithine-carbamoyltransferase and carbamoyl-phosphate synthetase).Promotes the production of insulin and growth hormone. Improves protein metabolism in diseases requiring parenteral nutrition. Helps reduce asthenic, dyspeptic and pain syndromes, as well as normalization of increased body weight (with steatosis and steatohepatitis).

    Pharmacokinetics:L-ornithine-L-aspartate rapidly dissociates into ornithine and aspartate, and begins to act for 15-25 minutes, with a short half-life. It is excreted in the urine through a cycle of urea formation.
    Indications:

    Acute and chronic liver disease, accompanied by hyperammonemia. Hepatic encephalopathy (latent and pronounced). Steatoses and steatohepatitis (of various origins).

    Contraindications:

    Severe renal failure with a creatinine score greater than 3 mg / 100 ml, hypersensitivity to the drug components, lactation period, children's age (due to insufficient data).

    Carefully:Pregnancy.
    Pregnancy and lactation:contraindicated in lactation, gently in pregnancy
    Dosing and Administration:Inside for 1-2 packets of granules dissolved in 200 ml of liquid, 3 times a day after meals. The course of admission depends on the severity of the disease.
    Side effects:

    From the gastrointestinal tract: infrequently: nausea, vomiting, abdominal pain, flatulence, diarrhea.

    From the side of the musculoskeletal and connective tissue: very rarely: pain in the limbs.

    Dye sunset sunset yellow can cause allergic reactions.

    Overdose:

    Symptoms: increased severity of side effects.

    Treatment: gastric lavage, reception of activated charcoal, symptomatic therapy.

    Special instructions:

    When diagnosing hepatic encephalopathy due to the underlying disease, care must be taken when driving vehicles and engaging in other potentially dangerous activities that require an increased concentration of attention and speed of psychomotor reactions.

    Form release / dosage:

    Granules for solution for oral administration, 3 g.

    Packaging:For 10 or 30 bags (5 g) of granules for the preparation of a solution for oral administration containing 3 g L- ornithine-Laspartate, packed in a cardboard box with instructions for use.
    Storage conditions:

    At a temperature of no higher than 25 ° C. In a place inaccessible to children.

    Shelf life:

    5 years.

    Do not use after the expiration date.

    Terms of leave from pharmacies:Without recipe
    Registration number:П N015093 / 01
    Date of registration:22.03.2007
    Expiration Date:02.09.2016
    The owner of the registration certificate:Merz Pharma GmbH & Co. KG. KGaAMerz Pharma GmbH & Co. KG. KGaA Germany
    Manufacturer: & nbsp
    Representation: & nbspMERZ PHARMA LLCMERZ PHARMA LLCRussia
    Information update date: & nbsp24.03.2017
    Illustrated instructions
      Instructions
      Up